See how your health system can retain specialty volume, strengthen financial performance, and improve patient outcomes with the right strategy and support. Health systems without fully integrated specialty pharmacy models…
Health systems build business cases for specialty pharmacy around predictable benefits: revenue retention, 340B optimization, and continuity of patient care. But the most significant impacts rarely appear in initial ROI…
Every year, more than 8,000 professionals and over 1,400 companies attend the leading specialty pharmacy conference in the nation, Asembia Summit 2025 marked its 21st anniversary — and we couldn’t be…
Accreditation positions health system specialty pharmacies to expand access to high-value medications and supports integrated caremodels shown to reduce healthcare costs.
This poster evaluates the impact of an ambulatory clinical pharmacist (ACP) program on third party pharmacy coverage determinationoutcomes for specialty oncology medications prescribed from these clinics.
This poster evaluate the challenges, time commitments, and resource allocation associated withachieving and maintaining SP accreditation among health-system specialty pharmacies.
This poster explores treatment utilization patterns and time to discontinuation (TTD) in patients receiving ALK TKIs for ALK+ mNSCLC.
This poster evaluates the clinical and quality outcomes of a bleeding disorder program in a health system specialty pharmacy.
This poster assesses the impact of re-training for specialty pharmacy outreach technicians by evaluating improvements in compliance knowledge, technician productivity, and patient enrollment rates.
This poster evaluates the clinical, safety, and quality outcomes of a pharmacist-led hypertrophic cardiomyopathy (HCM) clinical management program.